69
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Understanding deprescribing of preventive cardiovascular medication: a Q-methodology study in patients

, , , , &
Pages 975-984 | Published online: 23 May 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Nina D. Anfinogenova, Irina A. Trubacheva, Sergey V. Popov, Elena V. Efimova & Wladimir Y. Ussov. (2021) Trends and concerns of potentially inappropriate medication use in patients with cardiovascular diseases. Expert Opinion on Drug Safety 20:10, pages 1191-1206.
Read now

Articles from other publishers (10)

Laureline Brunner, Nicolas Rodondi & Carole Elodie Aubert. (2022) Barriers and facilitators to deprescribing of cardiovascular medications: a systematic review. BMJ Open 12:12, pages e061686.
Crossref
Kate Churruca, Kristiana Ludlow, Wendy Wu, Kate Gibbons, Hoa Mi Nguyen, Louise A. Ellis & Jeffrey Braithwaite. (2021) A scoping review of Q-methodology in healthcare research. BMC Medical Research Methodology 21:1.
Crossref
Evan Forest, Melissa Ireland, Uma Yakandawala, Teresa Cavett, Lalitha Raman-Wilms, Jamie Falk, Diana McMillan, Rhys Linthorst, Leanne Kosowan, Lisa Labine & Christine Leong. (2021) Patient values and preferences on polypharmacy and deprescribing: a scoping review. International Journal of Clinical Pharmacy 43:6, pages 1461-1499.
Crossref
Carole E. Aubert, Jin‐Kyung Ha, Hyungjin Myra Kim, Nicolas Rodondi, Eve A. Kerr, Timothy P. Hofer & Lillian Min. (2021) Clinical outcomes of modifying hypertension treatment intensity in older adults treated to low blood pressure. Journal of the American Geriatrics Society 69:10, pages 2831-2841.
Crossref
Jeanet W. Blom, Christiane Muth, Paul Glasziou, James P. McCormack, Rafael Perera, Rosalinde.K.E. Poortvliet, Mattijs E. Numans, Petra Thürmann, Ulrich Thiem, Sioe Lie Thio, Mieke Van Driel, Martin Beyer, Marjan Van den Akker & J. Andre Knottnerus. (2020) Describing deprescribing trials better: an elaboration of the CONSORT statement. Journal of Clinical Epidemiology 127, pages 87-95.
Crossref
Wade Thompson, Jette Videbæk Le, Peter Haastrup, Jesper Bo Nielsen, Line Bjørnskov Pedersen & Dorte Ejg Jarbøl. (2020) Exploring how GPs discuss statin deprescribing with older people: a qualitative study. BJGP Open 4:1, pages bjgpopen20X101022.
Crossref
Neil Drummond, Linda Garcia & Lynn McCleary. 2020. Evidence-Informed Approaches for Managing Dementia Transitions. Evidence-Informed Approaches for Managing Dementia Transitions 1 28 .
I. A. Zolotovskaya, D. V. Duplyakov, T. V. Zyuzina & I. L. Davydkin. (2019) Deprescribing of hypotensive therapy in hypertensive patients over 60 years (results of the program “GRANAT”). "Arterial’naya Gipertenziya" ("Arterial Hypertension") 25:3, pages 267-277.
Crossref
Clare Luymes, Rosalinde Poortvliet, Nan van Geloven, Margot de Waal, Yvonne Drewes, Jeanet Blom, Nynke Smidt, Willem Assendelft, Wilbert van den Hout, Wouter de Ruijter & Mattijs Numans. (2018) Staken preventieve cardiovasculaire medicatie bij laagrisicopatiënten. Huisarts en wetenschap 62:1, pages 38-41.
Crossref
Clare H. Luymes, Rosalinde K. E. Poortvliet, Nan van Geloven, Margot W. M. de Waal, Yvonne M. Drewes, Jeanet W. Blom, Nynke Smidt, Willem J. J. Assendelft, Wilbert B. van den Hout, Wouter de Ruijter & Mattijs E. Numans. (2018) Deprescribing preventive cardiovascular medication in patients with predicted low cardiovascular disease risk in general practice – the ECSTATIC study: a cluster randomised non-inferiority trial. BMC Medicine 16:1.
Crossref